Small cell carcinoma of the lung surgery: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 9: | Line 9: | ||
* Surgery should only be considered among patients with clinical stage I (T1-2, N0). Given that the majority of patients are not diagnosed with clinical stage I (T1-2, N0), surgery is rarely performed among SCCL patients.<ref name=NCCN>[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | * Surgery should only be considered among patients with clinical stage I (T1-2, N0). Given that the majority of patients are not diagnosed with clinical stage I (T1-2, N0), surgery is rarely performed among SCCL patients.<ref name=NCCN>[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | ||
* Before a patient is considered for surgical resection of the tumor, investigation for occult nodal involvement by either [[mediastinoscopy]] or mediastinal node dissection should be performed.<ref name=NCCN>[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | * Before a patient is considered for surgical resection of the tumor, investigation for occult nodal involvement by either [[mediastinoscopy]] or mediastinal node dissection should be performed.<ref name=NCCN>[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | ||
* Post-operative palliative treatment following surgery includes:<ref name=NCCN>[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | * Post-operative palliative treatment following surgery includes: | ||
** [[Small cell carcinoma of the lung medical therapy|Chemotherapy]] if there is no nodal involvement<ref name=NCCN>[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | |||
** [[Small cell carcinoma of the lung medical therapy|Chemotherapy]] PLUS [[small cell carcinoma of the lung radiation therapy|radiation therapy]] if there is nodal involvement | ** [[Small cell carcinoma of the lung medical therapy|Chemotherapy]] PLUS [[small cell carcinoma of the lung radiation therapy|radiation therapy]] if there is nodal involvement<ref name=NCCN>[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | ||
** Prophylactic cranial irradiation is recommended among patients who undergo complete resection of the tumor,<ref name="pmid10441603">{{cite journal| author=Aupérin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ et al.| title=Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. | journal=N Engl J Med | year= 1999 | volume= 341 | issue= 7 | pages= 476-84 | pmid=10441603 | doi=10.1056/NEJM199908123410703 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10441603 }} </ref> as long as their [[performance status]] is good and they do not have any neurological cognitive impairment. | ** Prophylactic cranial irradiation is recommended among patients who undergo complete resection of the tumor,<ref name="pmid10441603">{{cite journal| author=Aupérin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ et al.| title=Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. | journal=N Engl J Med | year= 1999 | volume= 341 | issue= 7 | pages= 476-84 | pmid=10441603 | doi=10.1056/NEJM199908123410703 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10441603 }} </ref> as long as their [[performance status]] is good and they do not have any neurological cognitive impairment.<ref name=NCCN>[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | ||
==References== | ==References== | ||
Revision as of 17:55, 8 June 2014
|
Small Cell Carcinoma of the Lung Microchapters |
|
Differentiating Small Cell Carcinoma of the Lung from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Small cell carcinoma of the lung surgery On the Web |
|
American Roentgen Ray Society Images of Small cell carcinoma of the lung surgery |
|
Directions to Hospitals Treating Small cell carcinoma of the lung |
|
Risk calculators and risk factors for Small cell carcinoma of the lung surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
In small cell carcinoma of the lung (SCCL), surgery should only be considered among patients with clinical stage I (T1-2, N0). Postoperative chemotherapy with or without radiation therapy is recommended based on the presence or absence of lymph node involvement.[1]
Surgery
- Surgery should only be considered among patients with clinical stage I (T1-2, N0). Given that the majority of patients are not diagnosed with clinical stage I (T1-2, N0), surgery is rarely performed among SCCL patients.[1]
- Before a patient is considered for surgical resection of the tumor, investigation for occult nodal involvement by either mediastinoscopy or mediastinal node dissection should be performed.[1]
- Post-operative palliative treatment following surgery includes:
- Chemotherapy if there is no nodal involvement[1]
- Chemotherapy PLUS radiation therapy if there is nodal involvement[1]
- Prophylactic cranial irradiation is recommended among patients who undergo complete resection of the tumor,[2] as long as their performance status is good and they do not have any neurological cognitive impairment.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014
- ↑ Aupérin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ; et al. (1999). "Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group". N Engl J Med. 341 (7): 476–84. doi:10.1056/NEJM199908123410703. PMID 10441603.